Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility.

ABSTRACT:

Objective

To evaluate the completeness and accessibility of public information about US clinical trials of drugs in development.

Design

Review of online registers of clinical trials.

Data sources

Drugs in phase III trials were identified using three drug industry sources: PhRMA Survey, What's in the Pipeline, and the NDA Pipeline. Drug trials were then searched for on the following publicly accessible registers of clinical trials:, and registers associated with the 37 "Comprehensive Cancer Centers" designated by the National Cancer Institute.

Main outcome measure

Extent of availability of public information on phase III trials of drugs in development for treating either prostate or colon cancer.

Results

Search of industry sources identified 12 drugs for

SUBMITTER: Manheimer E 

PROVIDER: S-EPMC124135 | biostudies-literature | 2002 Sep

REPOSITORIES: biostudies-literature